All Stories

  1. Respiratory viruses: their importance and lessons learned from COVID-19

    Article • European Respiratory Review, October 2022, European Respiratory Society (ERS)

    Dr CATIA CILLONIZ

  2. Outcomes of Critically ill Very old patients with Acute Respiratory Distress Syndrome and Community-Acquired Pneumonia

    Article • September 2021, European Respiratory Society (ERS)

    Dr CATIA CILLONIZ

  3. Impact on in-hospital mortality of Ceftaroline versus standard of care in Community-Acquired Pneumonia: A Propensity Matched Analysis

    Article • September 2021, European Respiratory Society (ERS)

    Dr CATIA CILLONIZ

  4. The Value of C-Reactive Protein-to-Lymphocyte Ratio in Predicting the Severity of SARS-CoV-2 Pneumonia

    Article • September 2021, European Respiratory Society (ERS)

    Dr CATIA CILLONIZ

  5. Pulse oximetry is an essential tool that saves lives: a call for standardisation

    Article • European Respiratory Journal, June 2021, European Respiratory Society (ERS)

    Dr CATIA CILLONIZ

  6. PES Pathogens in Elderly Patients with Acquired Pneumonia in the Community

    Article • September 2020, European Respiratory Society (ERS)

    Dr CATIA CILLONIZ

  7. Awareness and Pneumonia knowledge: where to start educating?

    Article • September 2020, European Respiratory Society (ERS)

    Dr CATIA CILLONIZ

  8. Methicillin-susceptible Staphylococcus aureus in Community-Acquired Pneumonia: Risk Factors and Outcomes

    Article • September 2020, European Respiratory Society (ERS)

    Dr CATIA CILLONIZ

  9. Can Artificial Intelligence Improve the Management of Pneumonia

    Article • Journal of Clinical Medicine, January 2020, MDPI AG

    Dr CATIA CILLONIZ

  10. Macrolide combination therapy for hospitalised CAP patients? An individualised approach supported by machine learning

    Article • European Respiratory Journal, December 2019, European Respiratory Society (ERS)

    Dr CATIA CILLONIZ

  11. Pneumocystis pneumonia in the twenty-first century: HIV-infected versus HIV-uninfected patients

    Article • Expert Review of Anti-infective Therapy, October 2019, Taylor & Francis

    Dr CATIA CILLONIZ

  12. Prevalence and risk factors of sepsis in very old patients with CAP

    Article • September 2019, European Respiratory Society (ERS)

    Dr CATIA CILLONIZ

  13. non invasive diagnosis of nosocomial pneumonia

    Article • Expert Review of Anti-infective Therapy, June 2019, Taylor & Francis

    Dr Adamantia Liapikou, Dr CATIA CILLONIZ

  14. Impact of Cefotaxime Non-susceptibility on the Clinical Outcomes of Bacteremic Pneumococcal Pneumonia

    Article • June 2019, MDPI AG

    Dr CATIA CILLONIZ

  15. Risk and Prognostic Factors in Very Old Patients with Sepsis Secondary to Community-Acquired pneumonia

    Article • June 2019, MDPI AG

    Dr CATIA CILLONIZ

  16. lymphopenia predicts mortality in patients with ICU pneumonia

    Article • Journal of Clinical Medicine, June 2019, MDPI AG

    Dr Adamantia Liapikou, Dr CATIA CILLONIZ

  17. Addendum: Cillóniz, C.; Dominedò, C.; Nicolini, A.; Torres, A. PES Pathogens in Severe Community-Acquired Pneumonia. Microorganisms 2019, 7, 49

    Article • Microorganisms, June 2019, MDPI AG

    Dr CATIA CILLONIZ

  18. Evaluation of the Magicplex™ Sepsis Real-Time Test for the Rapid Diagnosis of Bloodstream Infections in Adults

    Article • Frontiers in Cellular and Infection Microbiology, March 2019, Frontiers

    Dr CATIA CILLONIZ

  19. Multidrug Resistant Gram-Negative Bacteria in Community-Acquired Pneumonia

    Article • Critical Care, March 2019, Springer Science + Business Media

    Dr CATIA CILLONIZ

  20. PES Pathogens in Severe Community-Acquired Pneumonia

    Article • Microorganisms, February 2019, MDPI AG

    Dr CATIA CILLONIZ

  21. An international perspective on hospitalized patients with viral community-acquired pneumonia

    Article • European Journal of Internal Medicine, February 2019, Elsevier

    Dr Pedro J Marcos, Dr CATIA CILLONIZ

  22. Early noninvasive ventilation treatment for respiratory failure due to severe community-acquired pneumonia

    Article • Minerva Pneumologica, February 2019, Edizioni Minerva Medica

    Dr CATIA CILLONIZ

  23. Community-acquired pneumonia as an emergency condition

    Article • Current Opinion in Critical Care, December 2018, Wolters Kluwer Health

    Dr CATIA CILLONIZ

  24. Effect of Combined β-Lactam/Macrolide Therapy on Mortality According to the Microbial Etiology and Inflammatory Status of Patients with Community-Acquired Pneumonia

    Article • CHEST Journal, November 2018, Elsevier

    Dr CATIA CILLONIZ

  25. Reply to Head and Keynan

    Article • Clinical Infectious Diseases, October 2018, Oxford University Press (OUP)

    Dr CATIA CILLONIZ

  26. Drugs that increase the risk of community-acquired pneumonia: a narrative review

    Article • Expert Opinion on Drug Safety, September 2018, Taylor & Francis

    Dr CATIA CILLONIZ, Dr Adamantia Liapikou, antoni Torres

  27. Treating HIV-Positive/Non-AIDS Patients for Community-Acquired Pneumonia with ART

    Article • Current Infectious Disease Reports, September 2018, Springer Science + Business Media

    Dr CATIA CILLONIZ

  28. Clinical Approach to Community-acquired Pneumonia

    Article • Journal of Thoracic Imaging, September 2018, Wolters Kluwer Health

    Dr CATIA CILLONIZ

  29. Corticosteroid treatment in critically ill patients with severe influenza pneumonia: a propensity score matching study

    Article • Intensive Care Medicine, August 2018, Springer Science + Business Media

    Dr CATIA CILLONIZ

  30. Inflammatory response depends on time since onset of symptoms in pneumonia

    Article • American Review of Respiratory Disease, August 2018, American Thoracic Society

    Rosario Menéndez, Dr CATIA CILLONIZ

  31. MagicplexTM Sepsis real-time test for the rapid diagnosis of bloodstream infections in adults

    Article • July 2018, Cold Spring Harbor Laboratory Press

    Dr CATIA CILLONIZ

  32. Twenty-year trend in mortality among hospitalized patients with pneumococcal community-acquired pneumonia

    Article • PLoS ONE, July 2018, PLOS

    Dr CATIA CILLONIZ

  33. Burden and risk factors forPseudomonas aeruginosacommunity-acquired pneumonia: a multinational point prevalence study of hospitalised patients

    Article • European Respiratory Journal, July 2018, European Respiratory Society (ERS)

    Dr Marcos I. Restrepo, Dr CATIA CILLONIZ, Dr Pedro J Marcos

  34. Community-acquired bacterial pneumonia in adult HIV-infected patients

    Article • Expert Review of Anti-infective Therapy, July 2018, Taylor & Francis

    Dr CATIA CILLONIZ, antoni Torres

  35. Microorganisms resistant to conventional antimicrobials in acute exacerbations of chronic obstructive pulmonary disease

    Article • June 2018, Springer Science + Business Media

    Dr CATIA CILLONIZ

  36. Community-acquired Pneumonia and Acute Respiratory Distress Syndrome

    Article • Clinical Pulmonary Medicine, May 2018, Wolters Kluwer Health

    Dr CATIA CILLONIZ

  37. Characteristics and Management of Community-Acquired Pneumonia in the Era of Global Aging

    Article • Medical Sciences, April 2018, MDPI AG

    Dr CATIA CILLONIZ

  38. Community-Acquired Legionella Pneumonia in Human Immunodeficiency Virus–Infected Adult Patients: A Matched Case-Control Study

    Article • Clinical Infectious Diseases, April 2018, Oxford University Press (OUP)

    Dr CATIA CILLONIZ

  39. Burden of pneumococcal community-acquired pneumonia in adults across Europe: A literature review

    Article • Respiratory Medicine, April 2018, Elsevier

    Dr CATIA CILLONIZ

  40. Effectiveness of combination therapy versus monotherapy with a third-generation cephalosporin in bacteraemic pneumococcal pneumonia: A propensity score analysis

    Article • Journal of Infection, April 2018, Elsevier

    Dr CATIA CILLONIZ

  41. Acute respiratory distress syndrome in mechanically ventilated patients with community-acquired pneumonia

    Article • European Respiratory Journal, March 2018, European Respiratory Society (ERS)

    Dr CATIA CILLONIZ, Dr Adamantia Liapikou

  42. Detection of human cytomegalovirus in bronchoalveolar lavage of intensive care unit patients

    Article • European Respiratory Journal, February 2018, European Respiratory Society (ERS)

    Dr CATIA CILLONIZ

  43. Severe community-acquired pneumonia: Characteristics and prognostic factors in ventilated and non-ventilated patients

    Article • PLoS ONE, January 2018, PLOS

    Dr CATIA CILLONIZ

  44. New Sepsis Definition (Sepsis-3) and Community-acquired Pneumonia Mortality. A Validation and Clinical Decision-Making Study

    Article • American Review of Respiratory Disease, November 2017, American Thoracic Society

    antoni Torres, Dr CATIA CILLONIZ

  45. Respiratory infection: insights from Assembly 10 of the European Respiratory Society 2017 Annual Congress

    Article • Journal of Thoracic Disease, November 2017, AME Publishing Company

    MD MPhil Pouline van Oort, Dr CATIA CILLONIZ

  46. Has Mortality of Community-Acquired Pneumonia Really Reduced?

    Article • Clinical Pulmonary Medicine, November 2017, Wolters Kluwer Health

    Dr CATIA CILLONIZ

  47. Predictors of treatment failure and clinical stability in patients with community acquired pneumonia

    Article • Annals of Translational Medicine, November 2017, AME Publishing Company

    Dr CATIA CILLONIZ

  48. Adjuvant therapies in critical care: steroids in community-acquired pneumonia

    Article • Intensive Care Medicine, October 2017, Springer Science + Business Media

    Dr CATIA CILLONIZ

  49. Investigational drugs in phase I and phase II clinical trials for the treatment of community-acquired pneumonia

    Article • Expert Opinion on Investigational Drugs, October 2017, Taylor & Francis

    Dr Adamantia Liapikou, Dr CATIA CILLONIZ

  50. Lymphopenic Community Acquired Pneumonia (L-CAP), an Immunological Phenotype Associated with Higher Risk of Mortality

    Article • EBioMedicine, October 2017, Elsevier

    Dr CATIA CILLONIZ

  51. Evaluation of severity score-guided approaches to macrolide use in community-acquired pneumonia

    Article • European Respiratory Journal, September 2017, European Respiratory Society (ERS)

    Dr CATIA CILLONIZ

  52. The burden of PCV13 serotypes in hospitalized pneumococcal pneumonia in Spain using a novel urinary antigen detection test. CAPA study

    Article • Vaccine, September 2017, Elsevier

    Dr CATIA CILLONIZ

  53. Time to blood culture positivity as a predictor of clinical outcomes and severity in adults with bacteremic pneumococcal pneumonia

    Article • PLoS ONE, August 2017, PLOS

    Dr CATIA CILLONIZ

  54. Community-Acquired Pneumococcal Pneumonia in Virologically Suppressed HIV-Infected Adult Patients

    Article • CHEST Journal, August 2017, Elsevier

    Dr CATIA CILLONIZ

  55. Treatment with macrolides and glucocorticosteroids in severe community-acquired pneumonia: A post-hoc exploratory analysis of a randomized controlled trial

    Article • PLoS ONE, June 2017, PLOS

    Dr CATIA CILLONIZ

  56. Invasive Disease vs Urinary Antigen-Confirmed Pneumococcal Community-Acquired Pneumonia

    Article • CHEST Journal, June 2017, Elsevier

    Dr CATIA CILLONIZ

  57. Antibiotic therapy prior to hospital admission is associated with reduced septic shock and need for mechanical ventilation in patients with community-acquired pneumonia

    Article • Journal of Infection, May 2017, Elsevier

    Dr CATIA CILLONIZ

  58. Typical Presentation of Legionella pneumophila Community-Acquired Pneumonia

    Article • Revista Portuguesa de Pneumologia (English Edition), May 2017, Elsevier

    Dr CATIA CILLONIZ

  59. Research in community-acquired pneumonia: the next steps

    Article • Intensive Care Medicine, April 2017, Springer Science + Business Media

    Dr CATIA CILLONIZ

  60. Seasonality of pathogens causing community-acquired pneumonia

    Article • Respirology, January 2017, Wiley

    Dr CATIA CILLONIZ

  61. Microbial Etiology of Pneumonia: Epidemiology, Diagnosis and Resistance Patterns

    Article • International Journal of Molecular Sciences, December 2016, MDPI AG

    Dr CATIA CILLONIZ

  62. Laboratory diagnosis of pneumonia in the molecular age

    Article • European Respiratory Journal, November 2016, European Respiratory Society (ERS)

    antoni Torres, Dr CATIA CILLONIZ

  63. Delay in diagnosis of influenza A (H1N1)pdm09 virus infection in critically ill patients and impact on clinical outcome

    Article • Critical Care, October 2016, Springer Science + Business Media

    Professor Francisco J García-Peñalvo, Dr CATIA CILLONIZ

  64. Clinical management of community acquired pneumonia in the elderly patient

    Article • Expert Review of Respiratory Medicine, October 2016, Taylor & Francis

    Dr CATIA CILLONIZ

  65. Response

    Article • CHEST Journal, September 2016, Elsevier

    Dr CATIA CILLONIZ

  66. Community-Acquired Pneumonia Due to Multidrug- and Non–Multidrug-Resistant Pseudomonas aeruginosa

    Article • CHEST Journal, August 2016, Elsevier

    Dr CATIA CILLONIZ

  67. Community-acquired pneumonia related to intracellular pathogens

    Article • Intensive Care Medicine, June 2016, Springer Science + Business Media

    Dr CATIA CILLONIZ

  68. Predictive and prognostic factors in patients with blood-culture-positive community-acquired pneumococcal pneumonia

    Article • European Respiratory Journal, May 2016, European Respiratory Society (ERS)

    Dr JAVIER GARAU, antoni Torres, Dr CATIA CILLONIZ

  69. What is the clinical relevance of drug-resistant pneumococcus?

    Article • Current Opinion in Pulmonary Medicine, May 2016, Wolters Kluwer Health

    Dr CATIA CILLONIZ

  70. Multilobar bilateral and unilateral chest radiograph involvement: implications for prognosis in hospitalised community-acquired pneumonia

    Article • European Respiratory Journal, April 2016, European Respiratory Society (ERS)

    antoni Torres, Dr CATIA CILLONIZ

  71. Pneumococcal vaccination

    Article • Current Opinion in Infectious Diseases, April 2016, Wolters Kluwer Health

    Dr CATIA CILLONIZ

  72. Impact of neuraminidase inhibitors on influenza A(H1N1)pdm09-related pneumonia: an individual participant data meta-analysis

    Article • Influenza and Other Respiratory Viruses, February 2016, Wiley

    Dr Allison McGeer, Kamran Lankarani, Dr CATIA CILLONIZ

  73. Procalcitonin (PCT) levels for ruling-out bacterial coinfection in ICU patients with influenza: A CHAID decision-tree analysis

    Article • Journal of Infection, February 2016, Elsevier

    Dr CATIA CILLONIZ

  74. Bacteraemia in outpatients with community-acquired pneumonia

    Article • European Respiratory Journal, November 2015, European Respiratory Society (ERS)

    antoni Torres, Dr CATIA CILLONIZ

  75. Polymicrobial community-acquired pneumonia: An emerging entity

    Article • Respirology, October 2015, Wiley

    Dr CATIA CILLONIZ

  76. Sensitivity, Specificity, and Positivity Predictors of the Pneumococcal Urinary Antigen Test in Community-Acquired Pneumonia

    Article • Annals of the American Thoracic Society, October 2015, American Thoracic Society

    Dr CATIA CILLONIZ

  77. Ceftobiprole for the treatment of pneumonia: a European perspective

    Article • Drug Design Development and Therapy, August 2015, Dove Medical Press

    Dr CATIA CILLONIZ, Dr Adamantia Liapikou, antoni Torres

  78. Streptococcus pneumoniae-associated pneumonia complicated by purulent pericarditis: case series

    Article • Jornal Brasileiro de Pneumologia, August 2015, FapUNIFESP (SciELO)

    Dr CATIA CILLONIZ

  79. Microbiology and outcomes of community acquired pneumonia in non cystic-fibrosis bronchiectasis patients

    Article • Journal of Infection, July 2015, Elsevier

    Dr CATIA CILLONIZ

  80. New antimicrobial approaches to gram positive respiratory infections

    Article • Pulmonary Pharmacology & Therapeutics, June 2015, Elsevier

    Dr CATIA CILLONIZ

  81. Macrolide resistance and outcomes of patients with Streptococcus pneumoniae pneumonia.

    Article • American Journal of Respiratory and Critical Care Medicine, June 2015, American Thoracic Society

    Dr CATIA CILLONIZ, Dr Adamantia Liapikou

  82. Risk Factors Associated with Potentially Antibiotic-Resistant Pathogens in Community-Acquired Pneumonia

    Article • Annals of the American Thoracic Society, February 2015, American Thoracic Society

    Dr CATIA CILLONIZ

  83. Bacteraemia and antibiotic-resistant pathogens in community acquired pneumonia: risk and prognosis

    Article • European Respiratory Journal, January 2015, European Respiratory Society (ERS)

    Dr CATIA CILLONIZ, antoni Torres

  84. Severe community-acquired pneumonia: Severity and management

    Article • Community Acquired Infection, January 2015, Medknow

    Dr CATIA CILLONIZ, Dr Adamantia Liapikou

  85. Noninvasive ventilation for acute respiratory failure due to community-acquired pneumonia: A concise review and update

    Article • Community Acquired Infection, January 2015, Medknow

    Dr CATIA CILLONIZ, antonello nicolini

  86. Clinical Management of Bacterial Pneumonia

    Article • January 2015, Springer Science + Business Media

    Dr CATIA CILLONIZ

  87. Viral infections

    Article • December 2014, European Respiratory Society (ERS)

    Dr CATIA CILLONIZ

  88. Detection of Pneumonia Associated Pathogens Using a Prototype Multiplexed Pneumonia Test in Hospitalized Patients with Severe Pneumonia

    Article • PLoS ONE, November 2014, PLOS

    Dr CATIA CILLONIZ, Dr Peter Michael Keller

  89. Severity and outcomes of community acquired pneumonia in asthmatic patients

    Article • Respiratory Medicine, November 2014, Elsevier

    Dr CATIA CILLONIZ

  90. Predicting treatment failure in patients with community acquired pneumonia: a case-control study

    Article • July 2014, Springer Science + Business Media

    Dr CATIA CILLONIZ

  91. Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data

    Article • The Lancet Respiratory Medicine, May 2014, Elsevier

    Dr Allison McGeer, Dr CATIA CILLONIZ, Kamran Lankarani

  92. Lung abscess due to Streptococcus pneumoniae: a case series and brief review of the literature

    Article • Pneumonologia i Alergologia Polska, April 2014, VM Media SP. zo.o VM Group SK

    Dr CATIA CILLONIZ

  93. Epidemiology, antibiotic therapy and clinical outcomes of healthcare-associated pneumonia in critically ill patients: a Spanish cohort study

    Article • Intensive Care Medicine, March 2014, Springer Science + Business Media

    Dr CATIA CILLONIZ

  94. Community-acquired lung respiratory infections in HIV-infected patients: microbial aetiology and outcome

    Article • European Respiratory Journal, February 2014, European Respiratory Society (ERS)

    Dr CATIA CILLONIZ

  95. IgA level in plasma as a differential factor for influenza infection in severe viral pneumonia

    Article • Journal of Clinical Virology, February 2014, Elsevier

    Dr CATIA CILLONIZ

  96. Pneumococcal disease: Epidemiology and new vaccines

    Article • Community Acquired Infection, January 2014, Medknow

    Dr CATIA CILLONIZ

  97. Community-acquired viral pneumonia in human immunodeficiency virus infected patients

    Article • Community Acquired Infection, January 2014, Medknow

    Dr CATIA CILLONIZ

  98. Phenotyping community-acquired pneumonia according to the presence of acute respiratory failure and severe sepsis

    Article • Respiratory Research, January 2014, Springer Science + Business Media

    Dr CATIA CILLONIZ, Professor Stefano Aliberti

  99. Predicting Community-Acquired Pneumonia Etiology: Response

    Article • CHEST Journal, December 2013, Elsevier

    Dr CATIA CILLONIZ

  100. A Worldwide Perspective of Nursing Home-Acquired Pneumonia Compared With Community-Acquired Pneumonia

    Article • Respiratory Care, November 2013, Daedalus Enterprises

    Dr CATIA CILLONIZ

  101. IgM levels in plasma predict outcome in severe pandemic influenza

    Article • Journal of Clinical Virology, November 2013, Elsevier

    Dr CATIA CILLONIZ

  102. Microbial aetiology of healthcare associated pneumonia in Spain: a prospective, multicentre, case–control study

    Article • Thorax, October 2013, BMJ

    Dr CATIA CILLONIZ

  103. Impact of Age and Comorbidity on Cause and Outcome in Community-Acquired Pneumonia

    Article • CHEST Journal, September 2013, Elsevier

    Dr CATIA CILLONIZ, Professor Stefano Aliberti

  104. Multidrug-resistant pathogens in hospitalised patients coming from the community with pneumonia: a European perspective: Table 1

    Article • Thorax, June 2013, BMJ

    Dr CATIA CILLONIZ, Professor Stefano Aliberti

  105. Influence of Previous Use of Inhaled Corticoids on the Development of Pleural Effusion in Community-acquired Pneumonia

    Article • American Journal of Respiratory and Critical Care Medicine, June 2013, American Thoracic Society

    Dr CATIA CILLONIZ, Dr Jacobo Sellares

  106. Thrombocytosis Is a Marker of Poor Outcome in Community-Acquired Pneumonia

    Article • CHEST Journal, March 2013, Elsevier

    Dr CATIA CILLONIZ

  107. Epidemiology, Clinical Features, and Prognosis of Elderly Adults with Severe Forms of Influenza A (H1N1)

    Article • Journal of the American Geriatrics Society, March 2013, Wiley

    Dr CATIA CILLONIZ

  108. Systemic corticosteroids for community-acquired pneumonia: Reasons for use and lack of benefit on outcome

    Article • Respirology, January 2013, Wiley

    Dr CATIA CILLONIZ

  109. Macrolide-based regimens in absence of bacterial co-infection in critically ill H1N1 patients with primary viral pneumonia

    Article • Intensive Care Medicine, January 2013, Springer Science + Business Media

    Dr CATIA CILLONIZ

  110. Influenza A (H1N1) Pneumonia

    Article • Clinical Pulmonary Medicine, November 2012, Wolters Kluwer Health

    Dr CATIA CILLONIZ

  111. Pulmonary complications of pneumococcal community-acquired pneumonia: incidence, predictors, and outcomes

    Article • Clinical Microbiology and Infection, November 2012, Elsevier

    Dr CATIA CILLONIZ

  112. Invasive Pneumococcal Disease Today

    Article • Clinical Pulmonary Medicine, September 2012, Wolters Kluwer Health

    Dr CATIA CILLONIZ

  113. Bacterial co-infection with H1N1 infection in patients admitted with community acquired pneumonia

    Article • Journal of Infection, September 2012, Elsevier

    Dr CATIA CILLONIZ

  114. Entendimento da mortalidade em pneumonia pneumocócica bacterêmica

    Article • Jornal Brasileiro de Pneumologia, August 2012, FapUNIFESP (SciELO)

    Dr CATIA CILLONIZ

  115. Cytokine Activation Patterns and Biomarkers Are Influenced by Microorganisms in Community-Acquired Pneumonia

    Article • CHEST Journal, June 2012, Elsevier

    Dr CATIA CILLONIZ

  116. Pulmonary Complications Of Pneumococcal CAP: Incidence, Predictors, And Outcomes

    Article • May 2012, American Thoracic Society

    Dr CATIA CILLONIZ

  117. Corticosteroids In Community-Acquired Pneumonia: Therapeutic Reasons And Outcomes

    Article • May 2012, American Thoracic Society

    Dr CATIA CILLONIZ

  118. Influence Of Long-Term Use Of Inhaled Corticoids On The Development Of Pleural Effusion In Community Acquired Pneumonia

    Article • May 2012, American Thoracic Society

    Dr CATIA CILLONIZ, Dr Jacobo Sellares

  119. Thrombocytosis Is A Diagnostic And Prognostic Marker In Community-Acquired Pneumonia

    Article • May 2012, American Thoracic Society

    Dr CATIA CILLONIZ

  120. Corticosteroid therapy in patients with primary viral pneumonia due to pandemic (H1N1) 2009 influenza

    Article • Journal of Infection, March 2012, Elsevier

    Dr CATIA CILLONIZ

  121. Community-acquired pneumonia in outpatients: aetiology and outcomes

    Article • European Respiratory Journal, January 2012, European Respiratory Society (ERS)

    Dr CATIA CILLONIZ

  122. CD4+ cell counts and HIV-RNA levels do not predict outcomes of community-acquired pneumonia in hospitalized HIV-infected patients

    Article • International Journal of Infectious Diseases, December 2011, Elsevier

    Dr CATIA CILLONIZ

  123. CAP IN COPD PATIENTS

    Article • European Respiratory Journal, September 2011, European Respiratory Society (ERS)

    Dr CATIA CILLONIZ, Dr Adamantia Liapikou

  124. Clinical relevance of mixed respiratory viral infections in adults with influenza A H1N1

    Article • European Respiratory Journal, August 2011, European Respiratory Society (ERS)

    Dr CATIA CILLONIZ

  125. First influenza season after the 2009 pandemic influenza: report of the first 300 ICU admissions in Spain

    Article • Medicina Intensiva, May 2011, Elsevier

    Dr CATIA CILLONIZ

  126. Microbial aetiology of community-acquired pneumonia and its relation to severity

    Article • Thorax, January 2011, BMJ

    Dr CATIA CILLONIZ

  127. Community-acquired polymicrobial pneumonia in the intensive care unit: aetiology and prognosis

    Article • Critical Care, January 2011, Springer Science + Business Media

    Dr CATIA CILLONIZ

  128. Pandemic and post-pandemic Influenza A (H1N1) infection in critically ill patients

    Article • Critical Care, January 2011, Springer Science + Business Media

    Dr CATIA CILLONIZ

  129. Influenza pneumonia: a comparison between seasonal influenza virus and the H1N1 pandemic

    Article • European Respiratory Journal, November 2010, European Respiratory Society (ERS)

    Dr CATIA CILLONIZ

  130. Factors associated with inflammatory cytokine patterns in community-acquired pneumonia

    Article • European Respiratory Journal, July 2010, European Respiratory Society (ERS)

    Dr CATIA CILLONIZ

  131. Severe Mixed Community Acquired Pneumoniae

    Article • May 2010, American Thoracic Society

    Dr CATIA CILLONIZ

  132. Community-acquired Pneumonia In Outpatients: Microbial Etiology

    Article • May 2010, American Thoracic Society

    Dr CATIA CILLONIZ

  133. INDICATION OF PLEURAL DRAINAGE IN PARAPNEUMONIC EFFUSION: ADHERENCE TO THE AMERICAN COLLEGE OF CHEST PHYSICIANS’ GUIDELINES

    Article • May 2010, American Thoracic Society

    Dr CATIA CILLONIZ

  134. PARAPNEUMONIC EFFUSIONS ACCORDING TO THE CLASSIFICATION OF THE AMERICAN COLLEGE OF CHEST PHYSICIANS: CLINICAL CHARACTERISTICS

    Article • May 2010, American Thoracic Society

    Dr CATIA CILLONIZ, Dr Jacobo Sellares

  135. Healthcare-associated Pneumonia (HCAP): Clinical Features And Biomarkers

    Article • May 2010, American Thoracic Society

    Dr CATIA CILLONIZ

  136. Nursing home-acquired pneumonia: a 10 year single-centre experience

    Article • Thorax, April 2010, BMJ

    Dr CATIA CILLONIZ

  137. Impact of Smoking Habit on the Etiology of Community-Acquired Pneumonia (CAP).

    Article • April 2009, American Thoracic Society

    Dr CATIA CILLONIZ

  138. Community-Acquired Pneumonia: Etiology and Severity Scores.

    Article • April 2009, American Thoracic Society

    Dr CATIA CILLONIZ

  139. Complicated Pneumococcal Pneumonia in Adults.

    Article • April 2009, American Thoracic Society

    Dr CATIA CILLONIZ